Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation

European Journal of Immunology

Volumn 33, Issue 12, 2003, Pages 3473-3483

  Saraiva Câmara, Niels Olsen ^a   Sebille, Fabien ^a   Lechler, Robert I ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

CD8 T cell activation; Immunoregulation; Regulatory cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PERFORIN; TUMOR ANTIGEN; VIRUS ANTIGEN;

ARTICLE; CELL CONTACT; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REACTION OPTIMIZATION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0348013075     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323966     Document Type: Article

References (40)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2Rα chains (CD25). J. Immunol. 1995. 155: 1151-1164.
2. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998. 160: 1212-1218.
3. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 2000. 12: 1145-1155.
4. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 1999. 162: 5317-5326.
5. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
6. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/ suppressive state. Int. Immunol. 1998. 10: 1969-1980.
7. Hong, S., Wilson, M.T., Serizawa, I., Wu, L., Singh, N., Naidenko, O.V., Miura, T., Haba, T., Scherer D.C., Wel, J., Kronenberg, M., Koezuka, Y. and Van Kaer, L., The natural killer T cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
8. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., Leite-de-Moraes, M., Gourain, C., Shu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J. F. and Herbelin, A., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
9. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001. 413: 531-534.
10. Shi, F., Ljunggren, H.-G. and Sarvetnick, N., Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 2001. 22: 97-101.
11. Yang, Y. F., Tomura, M., Ono, S., Hamaoka, T. and Fujiwara, H., Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells. Int. Immunol. 2000. 12: 1669-1675.
12. Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F. and Wood, K., IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 2001. 166: 3789-3796.
13. Sanchez-Fueyo, A., Weber, M., Domenig, C., Strom, T. S. and Zheng, X. X., Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 2002. 68: 2274-2281.
14. +CD4 T cells in vivo after the induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 2001. 167: 188-195.
15. +high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 1245-1253.
16. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193: 1285-1294.
17. + T cells with regulatory properties from human blood. J. Exp. Med. 2001. 193: 1303-1310.
18. + T cells: a naturally occuring population of regulatory T cells. Blood 2001. 98: 2736-2744.
19. + T cells as immunoregulatory T cells in vitro. Eur. J. Immunol. 2002. 32: 2365-2375.
20. + T cells. J. Exp. Med. 1996. 183: 2669-2674.
21. + regulatory T cells prevent graft rejection: CTLA-4 and IL-10 dependent immunoregulation of alloresponses. J. Immunol. 2002. 18: 1080-1086.
22. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 2002. 196: 247-253.
23. + T helper cells. J. Exp. Med. 2002. 196: 255-260.
24. + immunoregulatory T cells, gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002. 16: 311-323.
25. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002. 3: 135-142.
26. + regulatory T cells constitutively expressing cytotoxic T lymphocytes-associated antigen 4. J. Exp. Med. 2000. 192: 303-309.
27. + cells regulate CD8 cell anergy in neonatal tolerant mice. Transplantation 1999. 68: 1891-1897.
28. + immunoregulatory cells. J. Immunol. 2001. 167: 1137-1140.
29. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 2002. 169: 5401-5404.
30. + T cells. Proc. Natl. Acad. Sci. USA 2002. 99: 8832-8837.
31. + T cells responses. J. Exp. Med. 2002. 196: 1585-1592.
32. Bystry, R. S., Aluvihare, V., Welch, K. A., Kallokourdis, M. and Betz, A. G., B cells and professional APC recruit regulatory T cells via CCL4. Nat. Immunol. 2001. 2: 1126-1132.
33. O'Shea, J. J., Ma, A. and Lipsky, P., Cytokines and autoimmunity. Nat. Rev. Immunol. 2002. 2: 37-45.
34. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001. 193: 1295-302.
35. + regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10. Int. Immunol. 2002. 14: 233-239.
36. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002. 99: 3493-3499.
37. + regulatory T cells from human peripheral blood. J. Immunol. 2001. 166: 7282-7289.
38. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 2002. 196: 401-406.
39. + regulatory T cells ex-vivo. Blood 2003. 102: 218G-2186.
40. Strehlau, J., Pavlakis, M., Lipman, M., Shapiro, M., Vasconcelos, L., Harmon, W. and Strom, T. B., Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc. Natl. Acad. Sci. USA 1997. 94: 695-700.